PANRETIN

This brand name is authorized in Estonia, Lithuania, Poland, United States

Active ingredients

The drug PANRETIN contains one active pharmaceutical ingredient (API):

1 Alitretinoin UNII 1UA8E65KDZ - ALITRETINOIN

Alitretinoin is a naturally-occurring endogenous hormone related to vitamin A, binds to and activates all known intracellular retinoid receptor subtypes (RAR, RAR, RAR, RXR, RXR, RXR). The efficacy of alitretinoin in treating KS lesions may be related to the demonstrated ability of alitretinoin to inhibit the in vitro growth of KS cells. Read about Alitretinoin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PANRETIN Gel	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XF02	Alitretinoin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XF Retinoids for cancer treatment
Discover more medicines within L01XF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1197637
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030180
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100313026
Country: US	FDA, National Drug Code	Identifier(s): 59212-601, 62856-601